JAMIE GHRIGSBY: Open Payments
NPI 1093039695 · MOULTON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,672 in 112 payments from 22 companies in 2025. Trend: 2023 $1,759 · 2024 $1,657 · 2025 $1,672
Food & beverage: $1,672
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 20 | $315 |
| ABBVIE INC. | 17 | $207 |
| Novo Nordisk Inc | 8 | $159 |
| Kowa Pharmaceuticals America, Inc. | 25 | $157 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $116 |
| Phathom Pharmaceuticals, Inc. | 6 | $112 |
| PFIZER INC. | 5 | $91 |
| Lundbeck LLC | 3 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $52 |
| Axsome Therapeutics, Inc. | 2 | $49 |
Products named: NUZYRA, ZORYVE, VRAYLAR, TRINTELLIX, VOQUEZNA, XHANCE, REXULTI, QULIPTA.
Industry payments across AL — which companies pay providers there.
